Please login to the form below
neurology
This page shows the latest neurology news and features for those working in and with pharma, biotech and healthcare.
Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug
The Danish drugmaker is already a big player in neurology and psychological diseases, and PD is a core focus for the company which has suffered some pipeline setbacks of late, including
Latest news
-
Biogen cuts $217m deal for Karyopharm neurology drug
Biogen cuts $217m deal for Karyopharm neurology drug. The biotech hopes to begin phase I trials of KPT-350 by the end of the year.
-
Sanofi licences Principia MS drug in $805m deal
The agreement allows Principia to maximize the BTK opportunity in neurology with a strong partner for PRN2246, while focusing internal resources on our lead BTK inhibitor in another therapeutic area, ”said
-
Alexion's Soliris gets US approval for myasthenia gravis
Alexion's Soliris gets US approval for myasthenia gravis. New neurology indication could contribute $1.2bn to sales, says analysts. ... The new indication represents the first foray for Alexion in neurology and a massive development for MG patients in
-
Axovant joins ever-growing Alzheimer’s failure club
We believe that the fight against Alzheimer's and other important areas of unmet need in neurology is too important to be derailed by this setback," said David Hung, Axovant’s
-
UCB’s antiepileptic drug gains new US indication
Jeff Wren, executive vice president and head of UCB ’s neurology patient value unit, said: “We are delighted that, with this new monotherapy indication for Briviact, we can support people with
More from news
Approximately 8 fully matching, plus 142 partially matching documents found.
Latest Intelligence
-
A quest for innovative solutions
Ecosystem. “I have the most beautiful job in the company because my team and I are exposed to the change externally, ”says Erik Janssen, UCB’s head of innovative solutions, Neurology
-
The good, the bad and the ugly
Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue, ”says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Neurology experienced slow growth, largely because few diseases are very well
-
Deal Watch October 2016
$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014. ... Lilly. AZD3293. $500 profit share. Neurology 2012. Impax US. Zomig US.
-
Deal Watch August 2016
So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC
-
Deal Watch October 2015
Over the past few years, Merck KGaA has been realigning its healthcare business to focus on oncology, immuno-oncology, immunology and neurology and so its partnership with BioMarin for treatments for
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Topas Therapeutics appoints chief development officer and chief medical officer
vice president, multiple sclerosis/neurology and immunology.
-
GW Pharmaceuticals strengthens research and development team
Volker has an impressive record of successful new drug development and obtaining regulatory approvals which together with his deep experience in neurology, makes him ideally suited to lead GW’s clinical
-
Sam Agus takes up new role at Hansa Medical
Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology. ... With experience in medical strategy,
-
J&J’s clinical research neuroscience director joins MedAvante
He also brings extensive experience in psychiatry, neurology and dermatology, making him an ideal addition to MedAvante's scientific leadership team.”.
-
Hanover Health bolsters PR leadership team
Davies moves to Hanover Health from Tonic Life Communications where he was a senior account director specialising in oncology and neurology product communications, having first joined as an account director in
More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest from PMHub
-
Forecasting in Forgotten Markets
Forecasting in Forgotten Markets. In this article, Anthony Woodhead, Business Development Manager for Black Swan Analysis, discusses the challenges facing innovators in markets like Dementia, which has attracted significant investment over time but
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’ s health and rare diseases.
-
90TEN boosts PR division with hires from Biosector 2 and Tonic
Patel moves to 90TEN following three years at Tonic Life Communications, where she worked on international accounts spanning oncology, neurology and medical devices.
-
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
And for the past 15 years Robert has been by her side for every visit to the neurology department.
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’ s health and rare diseases.
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
Featured jobs
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Genetic Digital
We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
